Covid, Di Perri: “Sotrovimab has resisted the different variants”

(Adnkronos) – Giovanni Di Perri, director of the infectious diseases department of the Amedeo di Savoia hospital in Turin, spoke on the sidelines of the meeting promoted in Rome by GlaxoSmithKline and entitled “mAbs in Early Treatment. Controversies and consensus in the fragile patient with Covid-19: we do not create antibodies”.